Table 6 Multivariate Cox proportional hazards model for analysis of survival in HBsAg-positive DLBCL patients
| Factors | HR | 95% CI | P value | |
|---|---|---|---|---|
| Lower | Upper | |||
| Age/year | ||||
| > 60 | 1.940 | 0.528 | 7.132 | 0.319 |
| ≤ 60 | 1 | - | - | |
| Ann Arbor stage | ||||
| I–II | 1 | – | – | 0.532 |
| III–IV | 1.500 | 0.421 | 5.337 | |
| B-symtoms | ||||
| Yes | 1.969 | 0.565 | 6.860 | 0.287 |
| No | 1 | – | – | |
| Elevated LDH | ||||
| Yes | 1.345 | 0.448 | 4.037 | 0.598 |
| No | 1 | – | – | |
| Treated with rituximab | ||||
| Yes | 0.294 | 0.102 | 0.843 | 0.023 |
| No | 1 | – | – | |
| Spleen involvement | ||||
| Yes | 3.725 | 1.444 | 9.614 | 0.007 |
| No | 1 | – | - | |
| Bcl-2&Myc Positive | ||||
| Yes | 2.270 | 0.879 | 5.862 | 0.090 |
| No | 1 | – | – | |